Keywords：专著资料, 全文在线浏览, 硝石矾石散的研究1995.9.12
Section Index
Application of Interferon in Hematological Diseases, February 27, 1995
Interferon (IFN-α) is produced by the body's biological cells under the influence of inducers and is a highly active glycoprotein. White blood cells produce IFN-α, fibroblasts produce IFN-β, and T lymphocytes produce IFN-γ.
Indications: chronic myelogenous leukemia, multiple myeloma, malignant lymphoma, malignant melanoma.
The optimal dosage is (1–3) × 10^7^ U/day, or even higher, with a treatment course of one month. It is generally believed that the dosage of this drug is positively correlated with its efficacy.
This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.